Home » Topics » BioWorld Science

BioWorld Science
RSS

Nerviano Medical Sciences patents new choline kinase inhibitors

Feb. 13, 2018

Clenbuterol improves muscle function in patients with late-onset Pompe disease

Feb. 13, 2018

WntResearch revises design of planned phase II study of Foxy-5

Feb. 13, 2018

Avid Bioservices and Oncologie enter agreement for PS-targeting program

Feb. 13, 2018

Kadmon reports phase II data on KD-025 in IPF

Feb. 13, 2018

Audentes Therapeutics begins dosing in phase I/II VALENS study

Feb. 13, 2018

Opiant Pharmaceuticals announces plans for intranasal nalmefene

Feb. 13, 2018

FDA approves Symdeko to treat underlying cause of cystic fibrosis

Feb. 13, 2018

Sirenas and BMS enter multitarget research collaboration

Feb. 13, 2018

Foundation Fighting Blindness to support development of ProQR's candidate for Usher syndrome 2A

Feb. 13, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...